South Africa Immunoassay For Neurological Biomarkers Market Size & Outlook
South Africa immunoassay for neurological biomarkers market, 2018-2030 (US$M)
Related Markets
South Africa immunoassay for neurological biomarkers market highlights
- The South Africa immunoassay for neurological biomarkers market generated a revenue of USD 80.9 million in 2023 and is expected to reach USD 183.7 million by 2030.
- The South Africa market is expected to grow at a CAGR of 12.4% from 2024 to 2030.
- In terms of segment, alzheimer's disease was the largest revenue generating application in 2023.
- Alzheimer's Disease is the most lucrative application segment registering the fastest growth during the forecast period.
Immunoassay for neurological biomarkers market data book summary
| Market revenue in 2023 | USD 80.9 million |
| Market revenue in 2030 | USD 183.7 million |
| Growth rate | 12.4% (CAGR from 2023 to 2030) |
| Largest segment | Alzheimer's disease |
| Fastest growing segment | Alzheimer's Disease |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder |
| Key market players worldwide | Qiagen NV, Abbott Laboratories, Merck & Co Inc, Johnson & Johnson, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Sysmex Corp, Merck KGaA, Roche Holding AG, Nimble Therapeutics |
Other key industry trends
- In terms of revenue, South Africa accounted for 1.0% of the global immunoassay for neurological biomarkers market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia immunoassay for neurological biomarkers market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 210.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunoassay For Neurological Biomarkers Market Scope
Immunoassay For Neurological Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa immunoassay for neurological biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay for neurological biomarkers market will help companies and investors design strategic landscapes.
Alzheimer's disease was the largest segment with a revenue share of 35.97% in 2023. Horizon Databook has segmented the South Africa immunoassay for neurological biomarkers market based on alzheimer's disease, parkinson's disease, multiple sclerosis, autism spectrum disorder covering the revenue growth of each sub-segment from 2018 to 2030.
Many multinational companies, such as F. Hoffmann-La Roche AG, are planning to focus on the South African market by forming joint ventures with local companies, such as The Southern African Laboratory Diagnostics Association (SALDA), which represents laboratory medicine in Southern Africa and distributes IVD tests, such as immunoassays, in the country.
Moreover, companies such as SGS SA are collaborating with the clinical team for the development and validation of innovative biomarker assays, which is boosting market growth. Various biomarkers have been developed for the diagnosis, treatment, and monitoring of neurodegenerative diseases, such as Parkinson’s, which is highly prevalent in the area.
In South Africa, it accounts for up to 1,077 deaths annually, with an incidence of 3.35 cases per 100,000 population. A number of neurological-related biomarkers for Parkinson’s have been identified, including specific αsynuclein species (phosphorylated α-synuclein at residue Ser129, pro-aggregating forms of α-synuclein in blood & CSF, and oligomeric α-synuclein).
Reasons to subscribe to South Africa immunoassay for neurological biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa immunoassay for neurological biomarkers market databook
-
Our clientele includes a mix of immunoassay for neurological biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa immunoassay for neurological biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into South Africa immunoassay for neurological biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa immunoassay for neurological biomarkers market size, by application, 2018-2030 (US$M)
South Africa Immunoassay For Neurological Biomarkers Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
